ZHEJIANG ANGLIKANG PHARMACEUTICAL CO.,LTD.

Andere talen Zhejiang AngLiKang Pharmaceutical CO.,LTD.

Aandelen

002940

CNE100003GC2

slotkoers Shenzhen S.E. Andere beurzen 00:00:00 07-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
15,76 ^CNY	+2,40%		-9,27%	-27,41%

07/06	Zhejiang Anglikang Pharmaceutical Co. Kondigt dividend in contanten aan op aandeel A voor het jaar 2023, betaalbaar op 17 juni 2024	CI
26/04	Zhejiang AngLiKang Pharmaceutical CO.,LTD. rapporteert resultaten voor het eerste kwartaal dat eindigde op 31 maart 2024	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Zhejiang Anglikang Pharmaceutical Co.,Ltd. Announces Cash Dividend on Share A for the Year 2023, Payable on June 17, 2024	07/06
Zhejiang AngLiKang Pharmaceutical CO.,LTD. Reports Earnings Results for the First Quarter Ended March 31, 2024	26/04
Tranche Update on Zhejiang AngLiKang Pharmaceutical CO.,LTD.'s Equity Buyback Plan announced on August 31, 2023.	02/04
Anglikang Pharmaceutical Signs Licensing Deal for Affinity Biomedical's Tumor Drug	06/02
Anglikang Pharma's Unit Gets Nod for Enalapril Maleate Tablets	29/01
Tranche Update on Zhejiang AngLiKang Pharmaceutical CO.,LTD.'s Equity Buyback Plan announced on August 31, 2023.	02/01
Tranche Update on Zhejiang AngLiKang Pharmaceutical CO.,LTD.'s Equity Buyback Plan announced on August 31, 2023.	10-10-23
Zhejiang AngLiKang Pharmaceutical CO.,LTD. announces an Equity Buyback for CNY 60 million worth of its shares.	30-08-23
Zhejiang AngLiKang Pharmaceutical CO.,LTD. authorizes a Buyback Plan.	30-08-23
Zhejiang AngLiKang Pharmaceutical CO.,LTD. Reports Earnings Results for the Half Year Ended June 30, 2023	25-08-23
Anglikang Pharmaceutical's Unit Gets Veterinary, GMP Certificates	17-08-23
Anglikang Pharmaceutical Registers Metabolism Disorder Drug in China	27-06-23
Anglikang Pharma Obtains Nod to Market Sevoflurane Active Pharma Ingredient in China	16-06-23
Zhejiang Anglikang Pharmaceutical Co.,Ltd. Announces Cash Dividend on A Shares for the Year 2022, Payable on May 19, 2023	12-05-23
Zhejiang AngLiKang Pharmaceutical CO.,LTD. Reports Earnings Results for the First Quarter Ended March 31, 2023	28-04-23
Zhejiang AngLiKang Pharmaceutical CO.,LTD. Approves Final Cash Dividend for 2022	24-04-23
Anglikang Pharma Signs Five-Year Purchase Agreement With European Firm	06-04-23
Zhejiang Anglikang Pharmaceutical Co.,Ltd. Proposes Final Cash Dividend for 2022	03-04-23
Zhejiang AngLiKang Pharmaceutical CO.,LTD. Reports Earnings Results for the Full Year Ended December 31, 2022	31-03-23
Anglikang Pharma’s Drug to Lower Hypertension Fails to Make It on China’s Drug Procurement List	30-03-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Zhejiang AngLiKang Pharmaceutical CO.,LTD.

Aandelen

002940

CNE100003GC2

Andere talen

Filters